Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial

Rationale: Daily high-dose aspirin therapy benefits many patients with aspirin-exacerbated respiratory disease but provides no benefit for aspirin-tolerant patients with asthma. Type 2 inflammation characterizes aspirin-exacerbated respiratory disease. Objectives: To determine whether high-dose aspi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Am J Respir Crit Care Med
Hlavní autoři: Cahill, Katherine N., Cui, Jing, Kothari, Parul, Murphy, Katherine, Raby, Benjamin A., Singer, Joseph, Israel, Elliot, Boyce, Joshua A., Laidlaw, Tanya M.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Thoracic Society 2019
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6775876/
https://ncbi.nlm.nih.gov/pubmed/30978291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201809-1755OC
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky